Leuprolide Completed Phase 3 Trials for Adenocarcinoma, Prostate Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01011751Treatment of Hot Flushes Caused by Leuprorelin 11.25 mg in Prostate Adenocarcinoma